3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
6
Terminated
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Lymphoma, B-Cell
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Teratoma
1
Seminoma
1
Sarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Osteosarcoma
1
Nonseminomatous germ cell tumor
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, T-Cell
1
Lymphoma, Primary Effusion
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, AIDS-Related
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Histiocytosis, Langerhans-Cell
1
Interventions
Radiotherapy
11
pembrolizumab
10
Nivolumab
10
Doxorubicin
10
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Cyclophosphamide
8
Biopsy
7
X-Rays
6
Ipilimumab
6
Radiation
5
Phantoms, Imaging
5
Ifosfamide
5
talimogene laherparepvec
4
cabozantinib
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
tazemetostat
3
selpercatinib
3
pazopanib
3
liposomal doxorubicin
3
fludarabine
3
Temozolomide
3
Etoposide
3
ulixertinib
2
tislelizumab
2
tipifarnib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Sarcoma
×
etoposide phosphate
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled